Cargando…

Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study

BACKGROUND: The Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE‐DAPT) score has been shown to predict out‐of‐hospital major bleeding after myocardial infarction treated with percutaneous coronary intervention and dual anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wester, Axel, Mohammad, Moman A., Olivecrona, Göran, Holmqvist, Jasminka, Yndigegn, Troels, Koul, Sasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751860/
https://www.ncbi.nlm.nih.gov/pubmed/34612051
http://dx.doi.org/10.1161/JAHA.121.020974
_version_ 1784631766590423040
author Wester, Axel
Mohammad, Moman A.
Olivecrona, Göran
Holmqvist, Jasminka
Yndigegn, Troels
Koul, Sasha
author_facet Wester, Axel
Mohammad, Moman A.
Olivecrona, Göran
Holmqvist, Jasminka
Yndigegn, Troels
Koul, Sasha
author_sort Wester, Axel
collection PubMed
description BACKGROUND: The Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE‐DAPT) score has been shown to predict out‐of‐hospital major bleeding after myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy (DAPT). However, large validation studies have been scarce and the discriminative ability for patients with a preexisting bleeding risk factor (elderly, underweight, women, anemia, kidney dysfunction, or cancer) in a real‐world setting is unknown. METHODS AND RESULTS: Patients undergoing percutaneous coronary intervention for myocardial infarction between 2008 and 2017 were included from the SWEDEHEART (Swedish Web System for Enhancement of Evidence‐Based Care in Heart Disease Evaluated According to Recommended Therapies) registry (n=66 295). The predictive value of the PRECISE‐DAPT score for rehospitalization with major bleeding during dual antiplatelet therapy was evaluated using receiver operating characteristic analyses. A high PRECISE‐DAPT score (≥25; n=13 894) was associated with increased risk of major bleeding (3.9% versus 1.8%; hazard ratio [HR], 2.2; 95% CI, 2.0–2.5; P<0.001) compared with a non‐high score (<25; n=52 401). The score demonstrated a c‐statistic of 0.64 (95% CI, 0.63–0.66). The discriminative ability of the score to further stratify bleeding risk in patients with preexisting bleeding risk factors was poor, especially in patients who are elderly (c‐statistic=0.57; 95% CI, 0.55–0.60) or underweight (c‐statistic=0.56; 95% CI, 0.51–0.61), for whom a non‐high PRECISE‐DAPT score was associated with similar bleeding risk as a high PRECISE‐DAPT score in the general myocardial infarction population. CONCLUSIONS: In this nationwide population‐based study, the PRECISE‐DAPT score performed moderately in the general myocardial infarction population and poorly in patients with preexisting bleeding risk factors, where its usefulness seems limited.
format Online
Article
Text
id pubmed-8751860
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87518602022-01-14 Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study Wester, Axel Mohammad, Moman A. Olivecrona, Göran Holmqvist, Jasminka Yndigegn, Troels Koul, Sasha J Am Heart Assoc Original Research BACKGROUND: The Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE‐DAPT) score has been shown to predict out‐of‐hospital major bleeding after myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy (DAPT). However, large validation studies have been scarce and the discriminative ability for patients with a preexisting bleeding risk factor (elderly, underweight, women, anemia, kidney dysfunction, or cancer) in a real‐world setting is unknown. METHODS AND RESULTS: Patients undergoing percutaneous coronary intervention for myocardial infarction between 2008 and 2017 were included from the SWEDEHEART (Swedish Web System for Enhancement of Evidence‐Based Care in Heart Disease Evaluated According to Recommended Therapies) registry (n=66 295). The predictive value of the PRECISE‐DAPT score for rehospitalization with major bleeding during dual antiplatelet therapy was evaluated using receiver operating characteristic analyses. A high PRECISE‐DAPT score (≥25; n=13 894) was associated with increased risk of major bleeding (3.9% versus 1.8%; hazard ratio [HR], 2.2; 95% CI, 2.0–2.5; P<0.001) compared with a non‐high score (<25; n=52 401). The score demonstrated a c‐statistic of 0.64 (95% CI, 0.63–0.66). The discriminative ability of the score to further stratify bleeding risk in patients with preexisting bleeding risk factors was poor, especially in patients who are elderly (c‐statistic=0.57; 95% CI, 0.55–0.60) or underweight (c‐statistic=0.56; 95% CI, 0.51–0.61), for whom a non‐high PRECISE‐DAPT score was associated with similar bleeding risk as a high PRECISE‐DAPT score in the general myocardial infarction population. CONCLUSIONS: In this nationwide population‐based study, the PRECISE‐DAPT score performed moderately in the general myocardial infarction population and poorly in patients with preexisting bleeding risk factors, where its usefulness seems limited. John Wiley and Sons Inc. 2021-10-06 /pmc/articles/PMC8751860/ /pubmed/34612051 http://dx.doi.org/10.1161/JAHA.121.020974 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Wester, Axel
Mohammad, Moman A.
Olivecrona, Göran
Holmqvist, Jasminka
Yndigegn, Troels
Koul, Sasha
Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
title Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
title_full Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
title_fullStr Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
title_full_unstemmed Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
title_short Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
title_sort validation of the 4‐item precise‐dapt score: a swedeheart study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751860/
https://www.ncbi.nlm.nih.gov/pubmed/34612051
http://dx.doi.org/10.1161/JAHA.121.020974
work_keys_str_mv AT westeraxel validationofthe4itemprecisedaptscoreaswedeheartstudy
AT mohammadmomana validationofthe4itemprecisedaptscoreaswedeheartstudy
AT olivecronagoran validationofthe4itemprecisedaptscoreaswedeheartstudy
AT holmqvistjasminka validationofthe4itemprecisedaptscoreaswedeheartstudy
AT yndigegntroels validationofthe4itemprecisedaptscoreaswedeheartstudy
AT koulsasha validationofthe4itemprecisedaptscoreaswedeheartstudy